EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanistic Insight into Intestinal α-Synuclein Aggregation in Parkinson’s Disease Using a Laser-Printed Electrochemical Sensor

Julia M Balsamo, Keren Zhou, Vinay Kammarchedu iD, Aida Ebrahimi iD, Elizabeth N Bess iD

ACS Chemical Neuroscience · 2024

DOI: 10.1021/acschemneuro.4c00106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Julia M Balsamo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of California, Irvine, California 92617, United States. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Corporation for Science Advancement, Paul G. Allen Frontiers Group, Frederick Gardner Cottrell Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aggregated deposits of the protein α-synuclein and depleting levels of dopamine in the brain correlate with Parkinson's disease development. Treatments often focus on replenishing dopamine in the brain; however, the brain might not be the only site requiring attention. Aggregates of α-synuclein appear to accumulate in the gut years prior to the onset of any motor symptoms. Enteroendocrine cells (specialized gut epithelial cells) may be the source of intestinal α-synuclein, as they natively express this protein. Enteroendocrine cells are constantly exposed to gut bacteria and their metabolites because they border the gut lumen. These cells also express the dopamine metabolic pathway and form synapses with vagal neurons, which innervate the gut and brain. Through this connection, Parkinson's disease pathology may originate in the gut and spread to the brain over time. Effective therapeutics to prevent this disease progression are lacking due to a limited understanding of the mechanisms by which α-synuclein aggregation occurs in the gut. We previously proposed a gut bacterial metabolic pathway responsible for the initiation of α-synuclein aggregation that is dependent on the oxidation of dopamine. Here, we develop a new tool, a laser-induced graphene-based electrochemical sensor chip, to track α-synuclein aggregation and dopamine level over time. Using these sensor chips, we evaluated diet-derived catechols dihydrocaffeic acid and caffeic acid as potential inhibitors of α-synuclein aggregation. Our results suggest that these molecules inhibit dopamine oxidation. We also found that these dietary catechols inhibit α-synuclein aggregation in STC-1 enteroendocrine cells. These findings are critical next steps to reveal new avenues for targeted therapeutics to treat Parkinson's disease, specifically in the context of functional foods that may be used to reshape the gut environment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseHumansDopamineElectrochemical TechniquesEnteroendocrine CellsGastrointestinal MicrobiomeLasers

Stichwörter der Autor:innen

LIG sensorParkinson’s diseasedopamineironpolyphenolsα-synuclein

Substanzen

alpha-SynucleinDopamineSNCA protein, human

Autor:innen und Institutionen

  • Department of Chemistry, University of California, Irvine, California 92617, United States.
  • School of Electrical Engineering and Computer Science, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.
  • Materials Research Institute, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.
  • Department of Biomedical Engineering, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.
  • Department of Molecular Biology and Biochemistry, University of California, Irvine, California 92617, United States.

ORCID-Profile: Vinay Kammarchedu, Aida Ebrahimi, Elizabeth N Bess

Förderung

  • Research Corporation for Science Advancement
  • Paul G. Allen Frontiers Group
  • Frederick Gardner Cottrell Foundation
  • Scialog

Zitieren

APA

Balsamo, J. M., Zhou, K., Kammarchedu, V., Ebrahimi, A., & Bess, E. N. (2024). Mechanistic Insight into Intestinal α-Synuclein Aggregation in Parkinson’s Disease Using a Laser-Printed Electrochemical Sensor. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00106

Vancouver

Balsamo JM, Zhou K, Kammarchedu V, Ebrahimi A, Bess EN. Mechanistic Insight into Intestinal α-Synuclein Aggregation in Parkinson’s Disease Using a Laser-Printed Electrochemical Sensor. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00106

BibTeX
@article{Balsamo2024,
  author = {Balsamo, Julia M and Zhou, Keren and Kammarchedu, Vinay and Ebrahimi, Aida and Bess, Elizabeth N},
  title = {Mechanistic Insight into Intestinal α-Synuclein Aggregation in Parkinson’s Disease Using a Laser-Printed Electrochemical Sensor},
  journal = {ACS Chemical Neuroscience},
  year = {2024},
  doi = {10.1021/acschemneuro.4c00106}
}
Kostenlos starten →